Skip to main content
profile image
Selected Works of John M. Pagel, MD, PhD
Article
A Phase I/II Study Of Fludarabine, Cyclophosphamide, Rituximab and Vorinostat Followed By Rituximab and Vorinostat Maintenance Therapy In Patients With Previously Untreated B-Cell Chronic Lymphocytic Leukemia (CLL) Or Small Lymphocytic Leukemia (SLL)
Blood (2013)
  • Ajay K. Gopal, University of Washington
  • Oliver W. Press, Fred Hutchinson Cancer Research Center
  • David G. Maloney, Fred Hutchinson Cancer Research Center
  • Stephen H. Petersdorf, Fred Hutchinson Cancer Research Center
  • Troy Wadsworth
  • Trevor W. Dennie
  • Yoshio Inoue
  • Karl J. Schultheiss
  • Kiarash Kojouri, Skagit Valley Hospital
  • Kelly M. Smith, University of Washington
  • Britt Kammerer, Fred Hutchinson Cancer Research Center
  • John M. Pagel, University of Washington
Disciplines
Publication Date
November 15, 2013
Citation Information
Ajay K. Gopal, Oliver W. Press, David G. Maloney, Stephen H. Petersdorf, et al.. "A Phase I/II Study Of Fludarabine, Cyclophosphamide, Rituximab and Vorinostat Followed By Rituximab and Vorinostat Maintenance Therapy In Patients With Previously Untreated B-Cell Chronic Lymphocytic Leukemia (CLL) Or Small Lymphocytic Leukemia (SLL)" Blood Vol. 122 Iss. 21 (2013) p. 4191 - 4191
Available at: http://works.bepress.com/john-pagel/118/